Despite a dip in earnings, Global Partners LP (GLP) showcases robust growth strategies and adaptability in a dynamic market ...

Billy Joel has been performing his hit songs all over the world for decades, but a recent concert in Connecticut didn't go as ...

Obesity is a major risk factor for joint failure because excess weight puts more stress on the implants, leading to ...

Shares of WW International (NASDAQ:WW) have reversed Thursday’s after-hours gains as guarded remarks from the company’s CEO ...

Ozempic and its ilk may do a lot of things, but raising the risk of suicide doesn’t appear to be one of them. Research out ...

Madrigal Pharmaceuticals' Rezdiffra had a strong launch with $103.3M in Q4 sales and solid liquidity. See why I have a ...

Eli Lilly is seeking to further cement its stance as a leader in weight loss drugs in an ad campaign calling out “unapproved” medications.

India's largest drugmaker by revenue Sun Pharmaceutical is aiming to launch its experimental anti-obesity and type 2 diabetes ...

The GLP-1 ad wars “Healthy Skepticism” comes weeks after Eli Lilly competitor and Ozempic-maker Novo Nordisk launched a print ...

Jab for joy? A landmark study of nearly 30,000 patients found that the use of GLP-1 medications, which include Wegovy and Ozempic, could have “an antidepressant effect,” suggesting ...

The life sciences industry experienced a dynamic year in 2024. As the public markets gained traction, IPO activity and venture investment saw ...

Health insurance companies are lobbying against proposals that would expand prescription access to weight-loss medications.